118 related articles for article (PubMed ID: 6124133)
1. Intermittent medication for stable schizophrenic outpatients: an alternative to maintenance medication.
Herz MI; Szymanski HV; Simon JC
Am J Psychiatry; 1982 Jul; 139(7):918-22. PubMed ID: 6124133
[TBL] [Abstract][Full Text] [Related]
2. Intermittent vs maintenance medication in schizophrenia. Two-year results.
Herz MI; Glazer WM; Mostert MA; Sheard MA; Szymanski HV; Hafez H; Mirza M; Vana J
Arch Gen Psychiatry; 1991 Apr; 48(4):333-9. PubMed ID: 1672588
[TBL] [Abstract][Full Text] [Related]
3. Serum neuroleptic levels, prolactin levels, and relapse: a two-year study of schizophrenic outpatients.
Faraone SV; Brown WA; Laughren TP
J Clin Psychiatry; 1987 Apr; 48(4):151-4. PubMed ID: 2881923
[TBL] [Abstract][Full Text] [Related]
4. [Detection of early warning signs in schizophrenic patients. Possible applications in prevention of recurrence].
Wiedemann G; Hahlweg K; Hank G; Feinstein E; Müller U; Dose M
Nervenarzt; 1994 Jul; 65(7):438-43. PubMed ID: 7800087
[TBL] [Abstract][Full Text] [Related]
5. Continuous versus targeted medication in schizophrenic outpatients: outcome results.
Carpenter WT; Hanlon TE; Heinrichs DW; Summerfelt AT; Kirkpatrick B; Levine J; Buchanan RW
Am J Psychiatry; 1990 Sep; 147(9):1138-48. PubMed ID: 1974743
[TBL] [Abstract][Full Text] [Related]
6. Antipsychotic medication: clinical guidelines for maintenance therapy.
Johnson DA
J Clin Psychiatry; 1985 May; 46(5 Pt 2):6-15. PubMed ID: 2859281
[TBL] [Abstract][Full Text] [Related]
7. [Prodromal symptoms in schizophrenic relapse: A descriptive and comparative study].
Bouhlel S; Jones Y; Khelifa E; Msolly M; Melki W; El-Hechmi Z
Encephale; 2012 Oct; 38(5):397-403. PubMed ID: 23062453
[TBL] [Abstract][Full Text] [Related]
8. Early, targeted pharmacotherapeutic intervention in schizophrenia.
Carpenter W
J Clin Psychiatry; 1986 May; 47 Suppl():23-9. PubMed ID: 2871012
[TBL] [Abstract][Full Text] [Related]
9. Intermittent medication for schizophrenic outpatients: who is eligible?
Chiles JA; Sterchi D; Hyde T; Herz MI
Schizophr Bull; 1989; 15(1):117-21. PubMed ID: 2566198
[TBL] [Abstract][Full Text] [Related]
10. [Patient modified medication: how do schizophrenic patients manage their neuroleptics?].
Hornung WP; Buchkremer G; Redbrake M; Klingberg S
Nervenarzt; 1993 Jul; 64(7):434-9. PubMed ID: 8103569
[TBL] [Abstract][Full Text] [Related]
11. Treating prodromal episodes to prevent relapse in schizophrenia.
Herz MI; Glazer W; Mirza M; Mostert M; Hafez H
Br J Psychiatry Suppl; 1989 Jul; (5):123-7. PubMed ID: 2574984
[No Abstract] [Full Text] [Related]
12. Clinical risk following abrupt and gradual withdrawal of maintenance neuroleptic treatment.
Viguera AC; Baldessarini RJ; Hegarty JD; van Kammen DP; Tohen M
Arch Gen Psychiatry; 1997 Jan; 54(1):49-55. PubMed ID: 9006400
[TBL] [Abstract][Full Text] [Related]
13. High dosage piperacetazine (Quide) in ambulatory schizophrenic patients--therapeutic efficacy and toxicity.
Donlon PT; Rada RT
Dis Nerv Syst; 1974 May; 35(5):231-6. PubMed ID: 17894106
[TBL] [Abstract][Full Text] [Related]
14. Withdrawal symptoms after long-term treatment with low-potency neuroleptics.
Chouinard G; Bradwejn J; Annable L; Jones BD; Ross-Chouinard A
J Clin Psychiatry; 1984 Dec; 45(12):500-2. PubMed ID: 6150030
[TBL] [Abstract][Full Text] [Related]
15. Survey of the adjuvant use of benzodiazepines for treating outpatients with schizophrenia.
Pecknold JC
J Psychiatry Neurosci; 1993 Mar; 18(2):82-4. PubMed ID: 8096393
[TBL] [Abstract][Full Text] [Related]
16. Double-blind, placebo-controlled, multicenter trial of selegiline augmentation of antipsychotic medication to treat negative symptoms in outpatients with schizophrenia.
Bodkin JA; Siris SG; Bermanzohn PC; Hennen J; Cole JO
Am J Psychiatry; 2005 Feb; 162(2):388-90. PubMed ID: 15677608
[TBL] [Abstract][Full Text] [Related]
17. [What should we recommend for schizophrenic patients: long-term drug prevention or interval treatment?].
Müller P
Nervenarzt; 1983 Sep; 54(9):477-85. PubMed ID: 6138720
[No Abstract] [Full Text] [Related]
18. Dose response of prophylactic antipsychotics.
Davis JM; Kane JM; Marder SR; Brauzer B; Gierl B; Schooler N; Casey DE; Hassan M
J Clin Psychiatry; 1993 Mar; 54 Suppl():24-30. PubMed ID: 8097195
[TBL] [Abstract][Full Text] [Related]
19. Prospective study of prodromal symptoms in schizophrenic relapse.
Heinrichs DW; Carpenter WT
Am J Psychiatry; 1985 Mar; 142(3):371-3. PubMed ID: 2857535
[TBL] [Abstract][Full Text] [Related]
20. Early intervention, time-limited, targeted pharmacotherapy of schizophrenia.
Carpenter WT; Heinrichs DW
Schizophr Bull; 1983; 9(4):533-42. PubMed ID: 6140752
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
